Huapont Life Sciences Company Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 11,950

Employees

  • Stock Symbol
  • 002004

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $0.69
  • (As of Tuesday Closing)

Huapont Life Sciences Company General Information

Description

Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.

Contact Information

Formerly Known As
Huapont-Nutrichem
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 69 Renhe Xingguang Avenue
  • Yubei District
  • Chongqing, 401121
  • China
+86
Primary Industry
Holding Companies
Other Industries
Biotechnology
Agricultural Chemicals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • No. 69 Renhe Xingguang Avenue
  • Yubei District
  • Chongqing, 401121
  • China
+86

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huapont Life Sciences Company Stock Performance

As of 17-Nov-2026, Huapont Life Sciences Company’s stock price is $0.69. Its current market cap is $1.36B with 1.98B shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.69 $0.69 $0.57 - $0.87 $1.36B 1.98B 28.2M $0.04

Huapont Life Sciences Company Financials Summary

As of 30-Sep-2026, Huapont Life Sciences Company has a trailing 12-month revenue of $1.62B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,788,730 2,911,611 2,801,108 2,760,944
Revenue 1,616,601 1,600,867 1,625,634 1,638,839
EBITDA 177,000 330,699 151,746 288,640
Net Income 83,028 99,173 (41,668) 42,703
Total Assets 4,281,843 4,148,982 4,034,256 4,334,762
Total Debt 1,031,711 1,039,060 1,217,723 1,216,862
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Huapont Life Sciences Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Huapont Life Sciences Company Investments & Acquisitions (10)

Huapont Life Sciences Company’s most recent deal was a Corporate with Maan Medical Cloud. The deal was made on 16-Aug-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Maan Medical Cloud 16-Aug-2023 Corporate Decision/Risk Analysis
Pregene 29-Sep-2020 Later Stage VC Drug Discovery
Histogen 29-Aug-2016 Later Stage VC Drug Discovery
Angionetics 11-Jul-2016 Secondary Transaction - Private Biotechnology
Beijing Nutrichem Laboratory 16-May-2016 Later Stage VC Specialty Chemicals
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Huapont Life Sciences Company ESG

Risk Overview

Risk Rating

Updated October, 31, 2023

36.51 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,766

Rank

Percentile

Pharmaceuticals

Industry

of 891

Rank

Percentile

Pharmaceuticals

Subindustry

of 435

Rank

Percentile

To view Huapont Life Sciences Company’s complete esg history, request access »

Huapont Life Sciences Company Exits (5)

Huapont Life Sciences Company’s most recent exit was on 29-Aug-2016 from Histogen. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Histogen 29-Aug-2016 Completed
  • 2 buyers
Beijing Nutrichem Laboratory 16-May-2016 Completed
Shandong Kaisheng New Materials 14-Apr-2014 Completed
CCAB Agro 15-Feb-2012 Completed
Beijing Nutrichem Laboratory 23-Dec-2011 Merger/Acquisition Completed
To view Huapont Life Sciences Company’s complete exits history, request access »

Huapont Life Sciences Company Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Rheintalklinik Bad Krozingen, Germany 1973
Paracelsus Klinik Lustmühle Teufen, Switzerland 1958
Nutrichem America

Huapont Life Sciences Company FAQs

  • When was Huapont Life Sciences Company founded?

    Huapont Life Sciences Company was founded in 1992.

  • Where is Huapont Life Sciences Company headquartered?

    Huapont Life Sciences Company is headquartered in Chongqing, China.

  • What is the size of Huapont Life Sciences Company?

    Huapont Life Sciences Company has 11,950 total employees.

  • What industry is Huapont Life Sciences Company in?

    Huapont Life Sciences Company’s primary industry is Holding Companies.

  • Is Huapont Life Sciences Company a private or public company?

    Huapont Life Sciences Company is a Public company.

  • What is Huapont Life Sciences Company’s stock symbol?

    The ticker symbol for Huapont Life Sciences Company is 002004.

  • What is the current stock price of Huapont Life Sciences Company?

    As of 17-Nov-2026 the stock price of Huapont Life Sciences Company is $0.69.

  • What is the current market cap of Huapont Life Sciences Company?

    The current market capitalization of Huapont Life Sciences Company is $1.36B.

  • What is Huapont Life Sciences Company’s current revenue?

    The trailing twelve month revenue for Huapont Life Sciences Company is $1.62B.

  • What is Huapont Life Sciences Company’s annual earnings per share (EPS)?

    Huapont Life Sciences Company’s EPS for 12 months was $0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process